Welcome to taking stock on...on Thursday 29th June 2023. It's a round up of today's business news & investment views. Including: Today's Indices, Winners & Losers, Most Read RNS's Plus Vadim Alexandre, Head of Healthcare at SP Angel discusses a UK listed healthcare micro cap that will benefit from their AI: Spectral MD #SMD.

(Watch the video interview HERE) Jeremy Skillington, CEO of Poolbeg Pharma (POLB ), talks us through the results of its successful collaboration with leading AI specialist CytoReason, making at a pioneer in AI-enabled drug discovery. 0:28 Discussing the results of the successful collaboration with AI-specialist CytoReason to study human challenge data for influenza, including validation of Poolbeg’s POLB001 treatment. 2:07 How the approach to analyse human challenge data for influenza with AI is the first of its kind. 3:28 Next steps after the successful conclusion of the collaboration, moving towards partnership. 4:54 Why Poolbeg is at the forefront of AI-enabled drug discovery